In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Novartis divests Miochol-E to prep for Alcon buy

Executive Summary

Bausch & Lomb Inc. has purchased from affiliates of Novartis AG a portion of the Miochol-E (acetylcholine) assets in the US, Canada, Australia, and Korea, as well as parts outside the European Economic Area. It will buy the remainder upon regulatory clearance.

Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)
    • Product Purchase

Related Companies